Miriam Boersema

1.5k total citations · 1 hit paper
24 papers, 1.2k citations indexed

About

Miriam Boersema is a scholar working on Molecular Biology, Hepatology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Miriam Boersema has authored 24 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Hepatology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Miriam Boersema's work include Liver physiology and pathology (7 papers), Liver Disease Diagnosis and Treatment (4 papers) and Renal Diseases and Glomerulopathies (4 papers). Miriam Boersema is often cited by papers focused on Liver physiology and pathology (7 papers), Liver Disease Diagnosis and Treatment (4 papers) and Renal Diseases and Glomerulopathies (4 papers). Miriam Boersema collaborates with scholars based in Netherlands, Germany and United States. Miriam Boersema's co-authors include Ruud A. Bank, Bram Piersma, Peter Olinga, Henricus A. M. Mutsaers, Theerut Luangmonkong, Su Suriguga, Geny M. M. Groothuis, Masum M. Mia, Jan‐Luuk Hillebrands and Rutger A. F. Gjaltema and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Journal of the American Society of Nephrology.

In The Last Decade

Miriam Boersema

24 papers receiving 1.2k citations

Hit Papers

Signaling in Fibrosis: TGF-β, WNT, and YAP/TAZ Converge 2015 2026 2018 2022 2015 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Signaling in Fibrosis: TGF-β, WNT, and YAP/TAZ Converge
    2015 351 citations Bram Piersma, Ruud A. Bank et al. Frontiers in Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Miriam Boersema Netherlands 15 410 242 240 220 171 24 1.2k
Tsutomu Kanda Japan 21 367 0.9× 430 1.8× 283 1.2× 367 1.7× 73 0.4× 75 1.4k
Steffen K. Meurer Germany 21 452 1.1× 235 1.0× 243 1.0× 156 0.7× 71 0.4× 38 1.0k
Eddy Van de Leur Germany 20 485 1.2× 263 1.1× 236 1.0× 146 0.7× 126 0.7× 40 1.1k
Gianna Galli Italy 20 640 1.6× 296 1.2× 227 0.9× 211 1.0× 48 0.3× 39 1.6k
John M. Edmison United States 10 438 1.1× 614 2.5× 136 0.6× 166 0.8× 100 0.6× 11 1.2k
Antonia D’Errico-Grigioni Italy 16 261 0.6× 270 1.1× 380 1.6× 274 1.2× 46 0.3× 25 982
Kerstin Abshagen Germany 20 307 0.7× 383 1.6× 415 1.7× 305 1.4× 56 0.3× 46 1.1k
Kazuhiro Otani Japan 23 366 0.9× 322 1.3× 320 1.3× 442 2.0× 120 0.7× 53 1.6k
Enis Kostallari United States 20 599 1.5× 649 2.7× 551 2.3× 213 1.0× 165 1.0× 33 1.4k
Norihisa Nishimura Japan 18 343 0.8× 497 2.1× 270 1.1× 226 1.0× 58 0.3× 71 1.1k

Countries citing papers authored by Miriam Boersema

Since Specialization
Citations

This map shows the geographic impact of Miriam Boersema's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miriam Boersema with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miriam Boersema more than expected).

Fields of papers citing papers by Miriam Boersema

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miriam Boersema. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miriam Boersema. The network helps show where Miriam Boersema may publish in the future.

Co-authorship network of co-authors of Miriam Boersema

This figure shows the co-authorship network connecting the top 25 collaborators of Miriam Boersema. A scholar is included among the top collaborators of Miriam Boersema based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miriam Boersema. Miriam Boersema is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Suriguga, Su, Mei Li, Theerut Luangmonkong, et al.. (2022). Distinct responses between healthy and cirrhotic human livers upon lipopolysaccharide challenge: possible implications for acute-on-chronic liver failure. American Journal of Physiology-Gastrointestinal and Liver Physiology. 323(2). G114–G125. 5 indexed citations
2.
Bigaeva, Emilia, et al.. (2021). Macromolecular Crowding as a Tool to Screen Anti-fibrotic Drugs: The Scar-in-a-Jar System Revisited. Frontiers in Medicine. 7. 615774–615774. 16 indexed citations
3.
Bigaeva, Emilia, Henricus A. M. Mutsaers, Michael Schou Jensen, et al.. (2020). Predictive Value of Precision-Cut Kidney Slices as an Ex Vivo Screening Platform for Therapeutics in Human Renal Fibrosis. Pharmaceutics. 12(5). 459–459. 14 indexed citations
4.
Bigaeva, Emilia, Eric J. Simon, Matthias Zwick, et al.. (2019). Transcriptomic characterization of culture-associated changes in murine and human precision-cut tissue slices. Archives of Toxicology. 93(12). 3549–3583. 26 indexed citations
5.
Bigaeva, Emilia, et al.. (2019). Growth factors of stem cell niche extend the life-span of precision-cut intestinal slices in culture: A proof-of-concept study. Toxicology in Vitro. 59. 312–321. 9 indexed citations
6.
Bigaeva, Emilia, Henricus A. M. Mutsaers, Dorenda Oosterhuis, et al.. (2019). Exploring organ-specific features of fibrogenesis using murine precision-cut tissue slices. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1866(1). 165582–165582. 12 indexed citations
7.
Bigaeva, Emilia, Anouk Oldenburger, Yong Oock Kim, et al.. (2019). PI3K inhibition reduces murine and human liver fibrogenesis in precision-cut liver slices. Biochemical Pharmacology. 169. 113633–113633. 18 indexed citations
8.
Luangmonkong, Theerut, Su Suriguga, Henricus A. M. Mutsaers, et al.. (2018). Targeting Oxidative Stress for the Treatment of Liver Fibrosis. Reviews of physiology, biochemistry and pharmacology. 175. 71–102. 219 indexed citations
9.
Boersema, Miriam, Annamaria Naggi, Giangiacomo Torri, et al.. (2017). Increased migration of antigen presenting cells to newly-formed lymphatic vessels in transplanted kidneys by glycol-split heparin. PLoS ONE. 12(6). e0180206–e0180206. 10 indexed citations
10.
Piersma, Bram, et al.. (2017). Ascorbic acid promotes a TGFβ1-induced myofibroblast phenotype switch. Physiological Reports. 5(17). e13324–e13324. 35 indexed citations
11.
Luangmonkong, Theerut, Su Suriguga, Emilia Bigaeva, et al.. (2017). Evaluating the antifibrotic potency of galunisertib in a human ex vivo model of liver fibrosis. British Journal of Pharmacology. 174(18). 3107–3117. 72 indexed citations
12.
Frenay, Anne-Roos S., Saleh Yazdani, Miriam Boersema, et al.. (2015). Incomplete Restoration of Angiotensin II - Induced Renal Extracellular Matrix Deposition and Inflammation Despite Complete Functional Recovery in Rats. PLoS ONE. 10(6). e0129732–e0129732. 5 indexed citations
13.
Piersma, Bram, Ruud A. Bank, & Miriam Boersema. (2015). Signaling in Fibrosis: TGF-β, WNT, and YAP/TAZ Converge. Frontiers in Medicine. 2. 59–59. 351 indexed citations breakdown →
14.
Boersema, Miriam, Gundel Harms, Marcory C. R. F. van Dijk, et al.. (2014). CD16+ monocytes with smooth muscle cell characteristics are reduced in human renal chronic transplant dysfunction. Immunobiology. 220(5). 673–683. 4 indexed citations
15.
Mia, Masum M., Miriam Boersema, & Ruud A. Bank. (2014). Interleukin-1β Attenuates Myofibroblast Formation and Extracellular Matrix Production in Dermal and Lung Fibroblasts Exposed to Transforming Growth Factor-β1. PLoS ONE. 9(3). e91559–e91559. 89 indexed citations
16.
Boersema, Miriam, Johanna W.A.M. Celie, Rik Mencke, et al.. (2013). Renal Heparan Sulfate Proteoglycans Modulate Fibroblast Growth Factor 2 Signaling in Experimental Chronic Transplant Dysfunction. American Journal Of Pathology. 183(5). 1571–1584. 11 indexed citations
17.
Bos, Eelke M., Rui Wang, Pauline M. Snijder, et al.. (2013). Cystathionine γ-Lyase Protects against Renal Ischemia/Reperfusion by Modulating Oxidative Stress. Journal of the American Society of Nephrology. 24(5). 759–770. 165 indexed citations
18.
Boersema, Miriam, Grietje Molema, Tri Q. Nguyen, et al.. (2012). Local Medial Microenvironment Directs Phenotypic Modulation of Smooth Muscle Cells After Experimental Renal Transplantation. American Journal of Transplantation. 12(6). 1429–1440. 13 indexed citations
19.
Boersema, Miriam, Harry van Goor, Marja J.A. van Luyn, et al.. (2009). Donor and Recipient Contribution to Transplant Vasculopathy in Chronic Renal Transplant Dysfunction. Transplantation. 88(12). 1386–1392. 16 indexed citations
20.
Boersema, Miriam, Mark Walther Boer, André Zandvoort, et al.. (2009). Donor and Recipient Origin of Mesenchymal and Endothelial Cells in Chronic Renal Allograft Remodeling. American Journal of Transplantation. 9(3). 463–472. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tsutomu Kanda Breakdown of academic impact, for papers by Steffen K. Meurer Breakdown of academic impact, for papers by Eddy Van de Leur Breakdown of academic impact, for papers by Gianna Galli Breakdown of academic impact, for papers by John M. Edmison Breakdown of academic impact, for papers by Antonia D’Errico-Grigioni Breakdown of academic impact, for papers by Kerstin Abshagen Breakdown of academic impact, for papers by Kazuhiro Otani Breakdown of academic impact, for papers by Enis Kostallari Breakdown of academic impact, for papers by Norihisa Nishimura
Rankless by CCL
2026